Oncolytics Biotech Inc (ONC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Oncolytics Biotech Inc (ONC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH63162D
  • |
  • Pages: 33
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company's lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indicated for the treatment of lung, ovarian, colorectal, pancreatic, prostate, breast, head and neck cancers. Reolysin is also undergoing various other clinical trials to determine its use in other types of cancer, such as for squamous cell carcinoma, metastatic colorectal cancer, metastatic melanoma trial, and non-small cell lung cancer. The company and its partners are conducting clinical trials in several countries across the world, including Canada and the US. Oncolytics is headquartered in Calgary, Alberta, Canada.

Oncolytics Biotech Inc (ONC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 4

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Oncolytics Biotech Inc, Medical Devices Deals, 2011 to YTD 2017 9

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 11

Equity Offering 11

Oncolytics Biotech to Raise USD20 Million in Public Offering of Common Stock 11

Oncolytics Biotech Completes First Tranche Of Private Placement Of Shares For US$1 Million 12

Oncolytics Biotech Completes Public Offering Of Common Stock For US$32 Million 12

Oncolytics Biotech Completes Private Placement Of Shares For US$21 Million 14

Oncolytics Biotech Raises US$7.87 Million Upon Exercise Of Warrants 15

Oncolytics Biotech Raises US$6.8 Million Upon Exercise Of Warrants 16

Oncolytics Biotech Inc-Key Competitors 18

Key Employees 19

Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Financial Announcements 21

May 05, 2017: Oncolytics Biotech Announces 2017 First Quarter Results 21

Mar 10, 2017: Oncolytics Biotech Announces 2016 Year-End Results 22

Nov 03, 2016: Oncolytics Biotech Announces 2016 Third Quarter Results 23

Aug 04, 2016: Oncolytics Biotech Announces 2016 Second Quarter Results 24

May 06, 2016: Oncolytics Biotech Announces 2016 First Quarter Results 25

Mar 11, 2016: Oncolytics Biotech Announces 2015 Year End Results 26

Corporate Communications 28

Jan 19, 2017: Oncolytics Biotech Appoints Dr. Matt Coffey to the Role of President and CEO 28

Dec 06, 2016: Oncolytics Biotech announces resignation of board member 29

Nov 10, 2016: Oncolytics Biotech Announces Appointment of New Chief Medical Officer 30

Nov 02, 2016: Oncolytics Biotech Announces Management Team Changes 31

Mar 24, 2016: Oncolytics Biotech Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33

List of Figures

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Oncolytics Biotech Inc, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Oncolytics Biotech Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Oncolytics Biotech Inc, Medical Devices Deals, 2011 to YTD 2017 9

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Oncolytics Biotech to Raise USD20 Million in Public Offering of Common Stock 11

Oncolytics Biotech Completes First Tranche Of Private Placement Of Shares For US$1 Million 12

Oncolytics Biotech Completes Public Offering Of Common Stock For US$32 Million 12

Oncolytics Biotech Completes Private Placement Of Shares For US$21 Million 14

Oncolytics Biotech Raises US$7.87 Million Upon Exercise Of Warrants 15

Oncolytics Biotech Raises US$6.8 Million Upon Exercise Of Warrants 16

Oncolytics Biotech Inc, Key Competitors 18

Oncolytics Biotech Inc, Key Employees 19

Oncolytics Biotech Inc, Subsidiaries 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Oncolytics Biotech Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16090
Site License
USD 500 INR 32180
Corporate User License
USD 750 INR 48270

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com